WHICH LIPID-LOWERING AGENT SHOULD BE USED 1ST

被引:0
|
作者
RUTLEDGE, DR
机构
来源
CLINICAL PHARMACY | 1991年 / 10卷 / 12期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:943 / 945
页数:3
相关论文
共 50 条
  • [1] Lipid-Lowering Therapy in CKD: Should We Use It and in Which Patients
    Kaysen, George A.
    BLOOD PURIFICATION, 2017, 43 (1-3) : 196 - 199
  • [2] THE BEST ANTIARRHYTHMIC AGENT WILL BE A LIPID-LOWERING AGENT
    ROBERTS, WC
    AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (19): : 1402 - 1402
  • [3] KETOCONAZOLE - A POTENT LIPID-LOWERING AGENT
    BEER, N
    JAKUBOVITZ, D
    TORTOLEDO, F
    ARTERIOSCLEROSIS, 1989, 9 (05): : A726 - A726
  • [4] GARLIC AS A LIPID-LOWERING AGENT - A METAANALYSIS
    SILAGY, CA
    NEIL, A
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF LONDON, 1994, 28 (01): : 39 - 45
  • [5] FDA approvals - Lipid-lowering agent
    不详
    GERIATRICS, 2000, 55 (08) : 16 - 16
  • [6] Should smoking be an indication for lipid-lowering therapy?
    Peeters, A
    Demos, LL
    McNeil, JJ
    MEDICAL JOURNAL OF AUSTRALIA, 1999, 170 (05) : 240 - 240
  • [7] Should smoking be an indication for lipid-lowering therapy?
    Forge, B
    MEDICAL JOURNAL OF AUSTRALIA, 1999, 171 (02) : 112 - 112
  • [8] Lipid-lowering agent sidesteps sude effects
    不详
    CHEMICAL & ENGINEERING NEWS, 2007, 85 (39) : 86 - 86
  • [9] Clinical evaluation of lecithin as a lipid-lowering agent
    Wojcicki, J
    Pawlik, A
    Samochowiec, L
    Kaldonska, M
    Mysliwiec, Z
    PHYTOTHERAPY RESEARCH, 1995, 9 (08) : 597 - 599